[go: up one dir, main page]

FR2952301B1 - "utilisation comme actif deodorant de l'histone h4 ou d'au moins un inducteur de l'expression de l'histone h4 et procede de traitement des odeurs corporelles" - Google Patents

"utilisation comme actif deodorant de l'histone h4 ou d'au moins un inducteur de l'expression de l'histone h4 et procede de traitement des odeurs corporelles"

Info

Publication number
FR2952301B1
FR2952301B1 FR1059272A FR1059272A FR2952301B1 FR 2952301 B1 FR2952301 B1 FR 2952301B1 FR 1059272 A FR1059272 A FR 1059272A FR 1059272 A FR1059272 A FR 1059272A FR 2952301 B1 FR2952301 B1 FR 2952301B1
Authority
FR
France
Prior art keywords
histone
deodorant
inducer
expression
treating body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1059272A
Other languages
English (en)
Other versions
FR2952301A1 (fr
Inventor
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of FR2952301A1 publication Critical patent/FR2952301A1/fr
Application granted granted Critical
Publication of FR2952301B1 publication Critical patent/FR2952301B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
FR1059272A 2009-11-12 2010-11-10 "utilisation comme actif deodorant de l'histone h4 ou d'au moins un inducteur de l'expression de l'histone h4 et procede de traitement des odeurs corporelles" Expired - Fee Related FR2952301B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27286909P 2009-11-12 2009-11-12

Publications (2)

Publication Number Publication Date
FR2952301A1 FR2952301A1 (fr) 2011-05-13
FR2952301B1 true FR2952301B1 (fr) 2012-05-11

Family

ID=43927765

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1059272A Expired - Fee Related FR2952301B1 (fr) 2009-11-12 2010-11-10 "utilisation comme actif deodorant de l'histone h4 ou d'au moins un inducteur de l'expression de l'histone h4 et procede de traitement des odeurs corporelles"

Country Status (1)

Country Link
FR (1) FR2952301B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884423B1 (en) * 1998-08-13 2005-04-26 Symbiotec Gmbh Antimicrobial histone H1 compositions, kits, and methods of use thereof
US20030224077A1 (en) * 2002-04-08 2003-12-04 Societe L'oreal S.A. Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
FR2914189A1 (fr) * 2007-03-26 2008-10-03 Oreal Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau.

Also Published As

Publication number Publication date
FR2952301A1 (fr) 2011-05-13

Similar Documents

Publication Publication Date Title
EP2018377A4 (fr) Dérivés de 2-pyrazinone destinés au traitement d'une maladie ou d'un état dans lequel l'inhibition de l'élastase neutrophile humaine a un effet bénéfique
WO2008156685A3 (fr) Cellules souches de tendons
BRPI1010302A2 (pt) composições e métodos para tratamento, inibição ou prevenção do desenvolvimento de uma doença patogênica de planta e método de extermínio, inibição ou prevenção do desenvolvimento de um organismo
BRPI0906028A2 (pt) "sistema de tratamento com pressão reduzida, vasilha de coleta para ser utilizada com um sistema de tratamento com pressão e método para coletar o exsudato de um local tecidual"
IL194948A0 (en) 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
BRPI0923821A2 (pt) "dispositivo para cultura de algas e/ou de microorganismos para o tratamento de um efluentes e de uma biofachada"
FR2925522B1 (fr) Procede de traitement superficiel d'un alliage de zirconium ou de hafnium, et piece ainsi traitee
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
PL2100508T3 (pl) Kompozycja do zwalczania chorób roślin oraz sposób zapobiegania i zwalczania chorób roślin
EP1875931A4 (fr) Epurateur de sang et procede d epuration
ATE452131T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
ATE496912T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
BRPI0906439A2 (pt) composições farmacêuticas que compreendem grânulos de lipase microbiana purificada e métodos para a prevenção ou tratamento de distúrbios digestivos
FR2953395B1 (fr) Semelle orthopedique comprenant des moyens de correction pour le traitement des metatarsalgies et des affections cutanees plantaires
BRPI0822994A2 (pt) Método e sistema para tratamento de odores fétidos provenientes de uma instalação de polpa
FR2922450B1 (fr) Utilisation de bacteries lactique pour la prevention et/ou le traitement de pathologies cutanees
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
FR2931842B1 (fr) Procede de traitement et de valorisation de coproduits siderurgiques riches en zinc.
FR2968935B1 (fr) Utilisation de particules d'aerogel hydrophobes comme actif deodorant ; procede de traitement des odeurs corporelles humaines
EP2716285A3 (fr) Nouveau procédé pour identifier des composés utiles pour le traitement et/ou la prévention de maladies liées à la perte osseuse
DE112010001393A5 (de) Pflanzen-extrakte zur behandlung von hauterkrankungen
EP2278981A4 (fr) Marqueurs biologiques, réponse au traitement contre la douleur, l inflammation et les lésions neuronales ou vasculaires, et procédés d utilisation afférents
BRPI0820964A2 (pt) Oxazolidinonas para o tratamento e/ou profilaxia de insuficiência cardíaca
FR2952301B1 (fr) "utilisation comme actif deodorant de l'histone h4 ou d'au moins un inducteur de l'expression de l'histone h4 et procede de traitement des odeurs corporelles"
FR2954136B1 (fr) Composition deodorante a base de peptides antimicrobiens et procede de traitement des odeurs corporelles

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20200911